Prurigo is a skin condition that causes intense itching. It often starts as small, raised bumps that might have a tiny blister on top. Over time, these bumps can become larger, scaly, and thickened, sometimes looking like a prune belly.
Every report comes from a Lived member, sent anonymously.
Have you tried Dupixent (Dupilumab) for Prurigo?
Prurigo is a name dermatologists use for skin conditions marked by intensely itchy bumps. Today it most often means chronic prurigo, usually called prurigo nodularis in the United States. In this condition, long-lasting itch leads to repeated scratching, and the scratching produces firm, raised bumps (nodules) or thickened patches that are themselves very itchy. That sets up an itch-scratch cycle in which the skin and the nerves supplying it become more sensitive over time. The bumps usually appear on both sides of the body, most often on the outer arms and legs and other areas that are easy to reach. They may be pink, red, skin-colored or dark brown, and they often scab, bleed or break open. Many people also feel burning, stinging or pain. Places a person cannot reach, such as the middle of the back, are often spared, which is a clue that scratching shapes the rash. Prurigo nodularis is not contagious. The word prurigo also appears in the names of a few unrelated conditions. Actinic prurigo is a rare sun-triggered rash, and prurigo pigmentosa is a rare rash linked to fasting or very low-carbohydrate diets. Short-lived itchy bumps, such as reactions to insect bites, are also sometimes called prurigo. These have different causes and treatments, so getting the specific diagnosis matters.
In most people, no single cause is found. Researchers think prurigo nodularis develops when overactive itch nerves and an overactive immune response reinforce each other, and the repeated scratching then thickens and scars the skin. It often appears alongside another condition that causes itch. About half of people with prurigo nodularis have or have had eczema (atopic dermatitis). It is also more common in people with diabetes, advanced kidney disease, liver disease including hepatitis C, untreated HIV, some lymphomas (cancers of the lymph system), and anxiety or depression. Some medicines, including certain cancer treatments, have been linked to it as well. The connection runs both ways in some cases: the other illness can drive the itch, and living with constant itch can worsen sleep and mood. It is most common in people over 50, though it can occur at any age. In one large US hospital study, Black patients were affected more often than white patients. These are associations, not proof that any one factor caused a particular person's condition.
A dermatologist can usually recognize prurigo nodularis from the skin and the history. The core features are itch lasting at least six weeks, signs of repeated scratching or rubbing, and multiple itchy bumps or patches. The clinician will ask how long the itch has lasted, how intense it is, how it affects sleep and daily life, and what medicines you take. Part of the assessment is looking for something behind the itch. Blood tests commonly check blood counts, kidney, liver and thyroid function, blood sugar, and hepatitis B and C, and an HIV test may be offered. This matters because prurigo nodularis is sometimes the first visible sign of another illness, such as lymphoma or untreated HIV. Other conditions can look similar, including scabies, insect bite reactions, skin-picking disorder, a blistering disease called pemphigoid, and thickened forms of lichen planus. A skin scraping or a skin biopsy (removing a small piece of numbed skin to examine under a microscope) helps when the rash looks unusual, another skin disease is suspected, or treatment is not working.
Treatment aims to calm the itch first, because breaking the itch-scratch cycle is what allows the bumps to flatten and the skin to heal. It also treats any underlying condition that is feeding the itch. Most plans start with the skin and step up as needed. For limited disease, a strong corticosteroid cream or ointment, sometimes covered with plastic or applied as a medicated tape, reduces inflammation and helps flatten bumps while blocking scratching. Calcineurin inhibitors such as tacrolimus (Protopic) or pimecrolimus (Elidel) are nonsteroid alternatives. Corticosteroid injections into stubborn individual bumps, freezing with liquid nitrogen, and anti-itch creams such as menthol, pramoxine or capsaicin are also used. Freezing is used cautiously on darker skin because it can leave light spots or scars. When many areas are involved, phototherapy (controlled ultraviolet light treatments, usually two or three clinic visits a week for several weeks) is a common next step. For moderate or widespread disease, two injected biologic medicines are approved by the US Food and Drug Administration (FDA) for adults with prurigo nodularis. Dupilumab (Dupixent) blocks signals involved in allergic-type inflammation and is injected under the skin every two weeks after a starting dose. Nemolizumab (Nemluvio) blocks a signal called interleukin-31 that drives itch and is injected every four weeks. In large trials, more than half of people on either drug had a major drop in itch by four to six months, compared with about one in five on placebo, and many also had clear or almost clear skin. Neither has been shown to be better than the other. The main trade-offs are eye irritation (conjunctivitis) with dupilumab and headache or new eczema with nemolizumab, along with cost and insurance approval. Older pill-based options, such as methotrexate or cyclosporine (drugs that suppress the immune system), gabapentin or pregabalin (nerve-calming medicines), and certain antidepressants, can help some people but rest on smaller studies and may need blood monitoring. Sedating antihistamines at bedtime can help with sleep, though they do little for the underlying itch. Newer pills called JAK inhibitors, which block immune signaling enzymes known as Janus kinases, are being studied but are not established for this condition. Counseling can help when itch is taking a toll on mood or sleep.
Prurigo nodularis is usually long-lasting, and without effective treatment it can persist for years. It can be treated but not cured, and the course differs from person to person. Itch often improves before the skin does: nodules take longer to flatten, and healed areas can leave scars or lighter or darker marks, especially when the condition went untreated for a long time. The itch is among the most severe of any skin condition, and it commonly disrupts sleep, work and social life. Anxiety and depression are more common in people with prurigo nodularis, and naming that burden to the care team is part of treatment, not a separate issue. Finding the right combination can take several tries. Clinicians usually reassess every few months, looking at itch, the number of bumps, sleep and quality of life, and adjust treatment if progress stalls. Between visits, everyday habits help reduce scratching: keeping nails short, covering itchy areas with clothing or breathable dressings, using fragrance-free moisturizers, and noticing personal triggers such as heat, sweating or stress.
See a clinician, ideally a dermatologist, if itchy bumps last more than two weeks, if itch keeps you awake, or if a treatment plan is not bringing the itch under control. A first evaluation is also a chance to check for an underlying illness. Contact your care team promptly if scratched areas look infected, or if you take dupilumab and notice new or worsening eye redness, pain or vision changes. Let them know too if itch is badly affecting your mood.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Prurigo is like, what's helped you, or ask the community a question.